IRIS Institutional Research Information System - OPENBS Open Archive UniBS

BUGLIONE DI MONALE E BASTIA, MICHELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.138
AS - Asia 5.857
EU - Europa 5.090
SA - Sud America 1.033
Continente sconosciuto - Info sul continente non disponibili 426
AF - Africa 146
OC - Oceania 21
Totale 25.711
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.904
SG - Singapore 1.994
CN - Cina 1.957
UA - Ucraina 1.009
BR - Brasile 869
IT - Italia 866
DE - Germania 816
HK - Hong Kong 675
PL - Polonia 615
FI - Finlandia 377
FR - Francia 358
VN - Vietnam 340
GB - Regno Unito 298
RU - Federazione Russa 256
TR - Turchia 235
IE - Irlanda 192
BD - Bangladesh 177
IN - India 165
CA - Canada 113
MX - Messico 63
AR - Argentina 56
ZA - Sudafrica 55
IQ - Iraq 49
ID - Indonesia 46
SE - Svezia 46
CZ - Repubblica Ceca 43
NL - Olanda 43
JP - Giappone 36
ES - Italia 35
EC - Ecuador 33
PK - Pakistan 26
CO - Colombia 24
UZ - Uzbekistan 24
AT - Austria 22
BE - Belgio 21
SA - Arabia Saudita 21
VE - Venezuela 21
NG - Nigeria 19
MA - Marocco 18
AU - Australia 17
LT - Lituania 15
EU - Europa 14
TN - Tunisia 13
GR - Grecia 12
EG - Egitto 10
IR - Iran 10
JM - Giamaica 10
PA - Panama 10
PY - Paraguay 10
CL - Cile 9
JO - Giordania 9
AL - Albania 8
BY - Bielorussia 8
MY - Malesia 8
NP - Nepal 8
OM - Oman 8
AE - Emirati Arabi Uniti 7
CR - Costa Rica 7
DZ - Algeria 7
HN - Honduras 7
IL - Israele 7
KE - Kenya 7
KG - Kirghizistan 7
PH - Filippine 7
SN - Senegal 7
CH - Svizzera 6
HU - Ungheria 6
TH - Thailandia 6
TT - Trinidad e Tobago 6
AZ - Azerbaigian 5
PT - Portogallo 5
TW - Taiwan 5
BG - Bulgaria 4
BO - Bolivia 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
LA - Repubblica Popolare Democratica del Laos 4
SV - El Salvador 4
KH - Cambogia 3
KR - Corea 3
KW - Kuwait 3
KZ - Kazakistan 3
LV - Lettonia 3
MU - Mauritius 3
NO - Norvegia 3
PE - Perù 3
PR - Porto Rico 3
RO - Romania 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
AM - Armenia 2
CY - Cipro 2
EE - Estonia 2
ET - Etiopia 2
GT - Guatemala 2
IS - Islanda 2
LB - Libano 2
NZ - Nuova Zelanda 2
SL - Sierra Leone 2
Totale 25.279
Salva come PNG Salva come JPEG
Città #
Ashburn 1.328
Fairfield 1.304
Woodbridge 1.085
Singapore 1.078
Jacksonville 729
Houston 699
Hong Kong 670
Warsaw 602
Seattle 574
Cambridge 540
Chandler 536
San Jose 527
Ann Arbor 495
Wilmington 473
Beijing 430
The Dalles 385
New York 361
Princeton 337
Los Angeles 250
Helsinki 220
Nanjing 212
Dublin 191
Dearborn 178
Istanbul 176
Lauterbourg 175
Dallas 150
Munich 146
Columbus 116
Brescia 112
Milan 107
Buffalo 100
Ho Chi Minh City 95
Shanghai 95
Nanchang 91
São Paulo 91
San Francisco 90
Des Moines 89
Council Bluffs 84
Moscow 84
San Diego 72
Santa Clara 68
Changsha 64
Orem 58
Chicago 56
Hanoi 53
Dong Ket 52
Shenyang 51
Jinan 50
Hebei 49
London 48
Tianjin 48
Turku 47
Washington 47
Redondo Beach 46
Boardman 42
Jiaxing 37
Denver 36
Montreal 36
Chennai 34
Kunming 34
Nuremberg 33
Brooklyn 32
Hangzhou 31
Johannesburg 31
Tokyo 31
Toronto 31
Jakarta 28
Poplar 28
Frankfurt am Main 27
Rio de Janeiro 27
Brno 26
Lancaster 25
Mexico City 25
Zhengzhou 25
Manchester 24
Phoenix 24
Rome 23
Tashkent 22
Brussels 21
Ningbo 21
Atlanta 20
Brasília 19
Abuja 18
Amsterdam 18
Kocaeli 18
Stockholm 18
Boston 17
Da Nang 17
Dhaka 17
Guangzhou 17
Ceto 16
Haikou 16
Mumbai 16
Quito 16
Taizhou 16
Ankara 15
Curitiba 15
Lanzhou 15
Nürnberg 15
Verona 15
Totale 16.902
Salva come PNG Salva come JPEG
Nome #
Low dose rate brachytherapy (LDR-BT) as monotherapy for early stage prostate cancer in Italy: practice and outcome analysis in a series of 2237 patients from 11 institutions 282
Light and shadows of a new technique: Isphoton total-skin irradiation using helical IMRT feasible, less complex and as toxic as the electrons one? 270
Correlation between Human Papillomavirus Status and Quantitative MR Imaging Parameters including Diffusion-Weighted Imaging and Texture Features in Oropharyngeal Carcinoma 269
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study 252
Overexpression of sialidase NEU3 increases the cellular radioresistance potential of U87MG glioblastoma cells 251
Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy 229
Pros-IT CNR: an Italian prostate cancer monitoring project 225
Mebendazole as a candidate for drug repurposing in oncology: An extensive review of current literature 224
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study 220
A neuro-oncologic challenge: the case of a large, aggressive, malignant meningioma of the skull base with paranasal sinus involvement 212
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 211
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 210
EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide 200
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 200
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage III and IV disease 194
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 194
Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors 192
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma 190
The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis 189
In reply to Borras et al. the strengthening of Radiation Oncologist role inside multidisciplinary arena within 2025 189
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 186
Radiotherapy in patients with HIV: current issues and review of the literature 185
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part I: evolving technical choices and survival 183
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage I and II disease 183
THE ROLE OF PRIMARY SURGERY AND EXTERNAL BEAM RADIATION THERAPY IN THE MANAGEMENT OF NON-METASTATIC DUCTAL PROSTATE CANCER: 20-YEAR OUTCOMES FROM A SINGLE INSTITUTION EXPERIENCE 180
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 178
Oligometastatic prostate cancer patients stratification: A molecular signature identified by liquid biopsy 178
Salvage therapy of small volume prostate cancer nodal failures: A review of the literature 176
Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed? 176
Primary cutaneous non-Hodgkin lymphoma: results of a retrospective analysis in the light of the recent ILROG guidelines 176
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease. 176
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer 175
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature 173
Exploring the role of enzalutamide in combination with radiation therapy: An in vitro study 173
Role of external beam radiotherapy in the treatment of relapsing meningioma 172
Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes 171
Cetuximab in the treatment of metastatic mucoepidermoid carcinoma of the salivary glands: a case report and review of literature. 170
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial 169
Changes in patterns of practice for prostate cancer radiotherapy in Italy 1995-2003. A survey of the Prostate Cancer Study Group of the Italian Radiation Oncology Society 168
Three-dimensional conformal radiotherapy, static intensity-modulated and helical intensity-modulated radiotherapy in glioblastoma. Dosimetric comparison in patients with overlap between target volumes and organs at risk. 168
Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus 167
Radiotherapy for adult medulloblastoma: Long term result from a single institution. A review of prognostic factors and why we do need a multi-institutional cooperative program 166
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part II: evolving technical choices and toxicity patterns 165
The growing role of biology in the treatment of glioblastoma: no more one kind of disease 165
Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme 165
Whole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT technique 165
Stereotactic radiotherapy with simultaneous integrated protection planning technique for synovial sarcoma with stomach abutment: A case report of a complete response 163
Postoperative radiotherapy for prostate cancer: the sooner the better and potential to reduce toxicity even further 163
CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL 163
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab 163
Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution. 162
Two months of radiation oncology in the heart of Italian “red zone” during COVID-19 pandemic: paving a safe path over thin ice 162
Could Concomitant Radio-Chemotherapy Improve the Outcomes of Early-Stage Node Negative Anal Canal Cancer Patients? A Retrospective Analysis of 122 Patients 160
From Molecular to Clinical Radiation Biology of Glioblastoma 160
Reply to 'Comment on 'Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study'' 160
Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance 159
Could Machine Learning Improve the Prediction of Pelvic Nodal Status of Prostate Cancer Patients? Preliminary Results of a Pilot Study 158
A single-center retrospective safety analysis of cyclin-dependent kinase 4/6 inhibitors concurrent with radiation therapy in metastatic breast cancer patients 158
Circulating Tumour Cells in locally advanced head and neck cancer: Preliminary report about their possible role in predicting response to non-surgical treatment and survival. 157
A simplified integrated molecular and immunohistochemistry-based algorithm allows high accuracy prediction of glioblastoma transcriptional subtypes 157
Predictive factors for oropharyngeal mycosis during radiochemotherapy for head and neck carcinoma and consequences on treatment duration. Results of mycosis in radiotherapy (MIR): A prospective longitudinal study 156
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 156
Open-source, low cost, high-reliability solutions for digital imaging systrems: example of a dicom router/Soluzioni Open Source per sistemi Low Cost e High Reliability per l'imaging digitale: l'esempio di un dicom router. 155
Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus 155
Letter to “Medial lingual lymph node metastasis in carcinoma of the tongue” 155
Patterns of practice and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985 and 2001 in 12 italian radiation oncology centers 153
Optimizing Radiation Treatment Decisions for Patients Who Receive Neoadjuvant Chemotherapy 150
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alterations: from Their Spatial Distribution to the Use in Clinical Practice 149
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 148
Policies for reirradiation of recurrent high-grade gliomas: a survey among Italian radiation oncologists 147
Circulating Tumour Cells in Clinical Practice: Can Lessons Learned From Locally Advanced/Metastatic Breast and Prostate Cancers Guide Their use for other Cancer Types? Lights and Shadows 146
Supratentorial Gliomas in Eloquent Areas: Which Parameters Can Predict Functional Outcome and Extent of Resection? 146
Gene expression profiling of olfactory neuroblastoma helps identify prognostic pathways and define potentially therapeutic targets 146
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 144
Cetuximab and Radiation Therapy in Head and Neck Cancer 144
A reappraisal of the role of PET and CT/PET in early stage Hodgkin's Disease (HD) in the experience of the florence and Brescia Universities. 143
The impact of tumor histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients 142
Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy 142
A case report on how facing it problems: improving the reliability of a dicom router system through an affordable backup solution. 141
The impact of the histology of primary tumor on RPA prognostic classifications in patients (pts) treated for brain metastases (BM). Retrospective analysis of 382 pts treated with hypofractionated whole brain radiotherapy (HWBRT). 140
Retreatment of recurrent adult medulloblastoma with radiotherapy: a case report and review of the literature. 140
Information Retrieval in Medicine: an Extensive Experimental Study 138
Exploiting Machine Learning for Predicting Nodal Status in Prostate Cancer Patients 137
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 136
The STYRO 2011 project: a survey on perceived quality of training among young Italian radiation oncologists. 135
Radiotherapy in low-grade glioma adult patients: a retrospective survival and neurocognitive toxicity analysis. 135
Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus 135
Low-dose Lung Radiotherapy for COVID-19-related Pneumonia: Preliminary Results of the Italian Mono-institutional COLOR-19 Trial 134
Reliability of prostate-specific antigen-marker in determining biochemical failure during the first 2 years after external beam radiation therapy and hormone therapy in patients with non-operated prostate cancer. 134
Radiation Tolerance of Normal Brain: QUANTEC 2010 and Beyond 134
Non-metastatic ductal adenocarcinoma of the prostate: pattern of care from an uro-oncology multidisciplinary group 134
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with “curative” intent 133
Post-ABVD/pre-radiotherapy 18F-FDG-PET provides additional prognostic information for early-stage Hodgkin lymphoma: A retrospective analysis on 165 patients 133
Short fractionation radiotherapy for early prostate cancer in the time of COVID-19: long-term excellent outcomes from a multicenter Italian trial suggest a larger adoption in clinical practice 132
HER-2 overexpression/amplification in Barrett's oesophagus predicts early transition from dysplasia to adenocarcinoma: a clinico-pathologic study. 130
In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: results of a multicentre observational study. 129
Anal squamous cell carcinoma: Impact of radiochemotherapy evolution over years and an explorative analysis of MRI prediction of tumor response in a mono-institutional series of 131 patients 128
Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO) 128
A Systematic Review on Intensity Modulated Radiation Therapy for Mediastinal Hodgkin's Lymphoma 128
Radical radiotherapy of bladder cancer retrospective analysis of a series of 459 patients treated in an Italian Institution 127
Totale 16.775
Salva come PNG Salva come JPEG
Categoria #
all - tutte 125.277
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 125.277
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.245 0 197 38 58 16 75 54 113 75 161 86 372
2022/20231.362 188 88 47 103 126 339 6 138 214 17 53 43
2023/20241.813 87 32 192 94 97 413 64 80 350 53 79 272
2024/20253.375 31 41 29 491 333 300 285 139 317 286 725 398
2025/20267.197 680 915 493 936 762 487 1.048 246 473 603 369 185
2026/2027378 272 106 0 0 0 0 0 0 0 0 0 0
Totale 25.711